In emergency situations, uncontrolled bleeding becomes the most critical factor between life and death. Whether in an operating room or at an accident scene, rapid blood loss creates a race against time. While traditional methods like gauze, pressure, and cauterization have long been used, innovation in this space has remained limited—until now.
In Cleveland, Georgia, Steve Lazar is leading a breakthrough approach to hemorrhage control. As the Founder and CEO of Medix LLC, he is developing advanced solutions designed to stop bleeding faster and more effectively. His work focuses on a unique material that forms an instant protective barrier when applied to a wound—offering a potentially life-saving advantage in critical moments.
From Entrepreneur to Biotech Innovator
Unlike many in the biotech field, Steve Lazar does not come from a medical or scientific background. In fact, he openly admits that chemistry was once a challenge for him during his college years. However, his career path took a different direction, leading him into entrepreneurship.
Over four decades, he built and managed multiple businesses, gaining expertise in leadership, strategy, and execution. These experiences ultimately prepared him for a new mission—one that would bring him closer to the medical world that had fascinated him since childhood.
Early Inspiration and a New Direction
Steve’s interest in healthcare can be traced back to his upbringing. His mother worked alongside early pioneers in cardiology, sharing stories about life-saving innovations and medical breakthroughs. Those experiences left a lasting impression, inspiring him to one day contribute to the field.
Years later, that opportunity came in an unexpected form: a natural compound called chitosan.
Chitosan: A Natural Solution to a Critical Problem
Chitosan is derived from chitin, a substance found in the shells of crustaceans like shrimp and crabs. What makes it remarkable is its ability to rapidly interact with blood cells, helping to form a stable clot almost instantly.
Recognizing its potential, Steve Lazar saw an opportunity to create a more effective solution for bleeding control. This led to the development of ProClot, a hydrogel-based product designed to stop bleeding quickly while being safe and easy to use.
How ProClot Works
ProClot is designed to simplify emergency care. When applied to a wound, it forms a gel-like barrier that helps control bleeding efficiently. Unlike traditional materials that may need to be removed—sometimes disrupting the clot—this solution is biodegradable and remains in place.
Key benefits include:
- Rapid clot formation to control bleeding
- Biocompatible and biodegradable composition
- No need for removal from the wound
- Effective even for patients on blood thinners
- Safe for individuals with bleeding disorders
By extending the critical “golden hour” after injury, ProClot provides valuable time for patients to receive advanced medical care.
Expanding Beyond Hemorrhage Control
While ProClot is a major innovation, Steve Lazar’s vision for Medix goes further. The company aims to expand the use of chitosan-based technology into areas such as:
- Chronic wound treatment
- Drug delivery systems
- Advanced regenerative applications
This broader approach reflects a long-term goal of transforming how medical treatments are delivered and improving overall patient outcomes.
Leadership Approach and Business Philosophy
Running a biotech company comes with significant challenges, especially in a highly regulated environment. From compliance requirements to funding pressures, the journey requires persistence and adaptability.
Steve approaches this process with a practical mindset. Rather than focusing on short-term milestones, he views progress as a continuous journey—similar to learning a new skill step by step. His leadership style emphasizes:
- Consistent effort and long-term focus
- Open communication within teams
- Learning from past mistakes
- Encouraging innovation through collaboration
Balancing Responsibility and Vision
As Medix continues to grow, the responsibility has expanded beyond personal success to include the well-being of his team and the impact of the company’s products. Steve acknowledges that this phase of his career is the most demanding, requiring full dedication and focus.
Despite the challenges, his motivation remains clear: to bring effective, accessible solutions to people who need them most.
A Vision for the Future of Emergency Care
Looking ahead, Steve Lazar envisions a future where advanced bleeding control solutions are widely available—in hospitals, ambulances, and even personal first-aid kits. His goal is to ensure that critical care tools are accessible when and where they are needed most.
At its core, his mission is simple: to help save lives by improving how we respond to medical emergencies.
Conclusion
Steve Lazar’s journey highlights how innovation can come from unexpected places. From a business background to leading advancements in wound care, his work demonstrates the power of persistence, vision, and adaptability.
Through Medix and its technologies, he is contributing to a future where emergency medical care is faster, more effective, and more accessible—ultimately helping more people survive critical situations.